1. Introduction {#sec1}
===============

Aging in most species is associated with impaired adaptive and homeostatic mechanisms, leading to susceptibility to environmental or internal stresses with increasing rates of disease \[[@B1], [@B2]\]. A number of different theories of primarily disease-independent renal aging, which can be categorized as evolutionary, molecular, cellular, and systemic, have been proposed in the past and recent studies have provided evidence for some of these theories \[[@B3]\].

Age-related changes lead to a functional decline of several organs, including the kidney \[[@B4]\]. Age-related changes in renal structure and function have been described \[[@B5]\], not just in humans but in a wide range of other species, including rats, mice, hamsters, dogs, and cats. Modifications of the kidneys related to aging include changes to glomerular structure. As the functional kidney becomes older, there is glomerular basement membrane thickening and wrinkling associated with loss of capillary loops, and mesangial matrix expansion that may be the outcome of an imbalance between formation and removal of extracellular matrix \[[@B6]\].

Mild changes in renal function with aging are often accompanied by tubular functional changes, which may not necessarily be recognized in humans unless they lead to disease or accentuation of a pathological condition. These changes include a reduction in sodium homeostasis associated with the loss of the ability to concentrate or dilute the urine to the degree seen in younger individuals \[[@B7]\], which can accentuate dehydration in the elderly. There is also impairment of transport of a range of other electrolytes and ions across the tubular epithelium, as well as reduced drug excretion. Direct and indirect hormonal functions of the kidney also change with age, including blunted renin responses \[[@B8]\].

It is well known that the aging process is associated with disturbances of normal intracellular physiological phenomena including telomere shortening, reduction in Klotho expression, inactivation of silent information regulator T1 (SIRT1), activation of the renin-angiotensin system, and oxidative stress. Diabetes and metabolic syndrome are considered to contribute to the same types of organ damage as the aging process, especially in the kidneys, heart, and nerves. We therefore examined the processes of renal change during the aging process in mice, focusing on the changes in SIRT1,peroxisome proliferator-activated receptor *α* (PPAR*α*), Klotho, and oxidative stress-related enzymes \[[@B9]--[@B11]\].

2. Materials and Methods {#sec2}
========================

2.1. Animal Model {#sec2.1}
-----------------

The Animal Care Committee of The Catholic University approved the experimental protocol. Aging C57BL/6 mice were purchased from the Korea Research Institute of Bioscience and Biotechnology (Chungcheongbuk-do, Republic of Korea). Mice were housed in a controlled temperature and controlled light environment. Mice were divided into three groups as follows: 2-month-old group (2 M group, *n* = 5), 12-month-old group (12 M group, *n* = 5), and 24-month-old group (24 M group, *n* = 4).

2.2. Renal Function {#sec2.2}
-------------------

Mice were placed in individual mouse metabolic cages (Tecniplast, Gazzada, Italy) with access to water and food for 24 h to collect urine for subsequent measurements of albumin and creatinine concentrations. Albuminuria (Albuwell M, Exocell, Philadelphia, PA) and urine creatinine (The Creatinine Companion, Exocell) were measured using ELISA kits. Measurement of serum creatinine concentrations performed at Samkwang Medical Laboratories (Seoul, Korea) using enzymatic colorimetric methods (Modular DPP system, Roche, Hamburg, Germany). Creatinine clearance was calculated using a standard formula (urine creatinine (mg/dL) × urine volume (mL/24 h)/serum creatinine (mg/dL) × 1440 (min/24 h)).

2.3. Histology {#sec2.3}
--------------

Kidney samples were fixed in 10% formalin. The tissues were embedded in low-temperature melting paraffin, and 4-*μ*m sections were processed and stained with hematoxylin-eosin (HE), periodic acid-Schiff (PAS), and Masson\'s trichrome. The glomerular volume and mesangial area were determined by examining PAS sections using a color-image analyzer (TDI Scope Eye, Version 3.5 for Windows, Olympus, Tokyo, Japan). The relative mesangial area was expressed as mesangial/glomerular surface area. A finding of tubulointerstitial fibrosis was defined as a matrix-rich expansion of the interstitium with tubular dilatation, tubular atrophy, tubular cast formation and thickening of the tubular basement membrane. Ten fields per section were assessed.

2.4. Immunohistochemistry {#sec2.4}
-------------------------

Paraffin sections were deparaffinized in xylene and hydrated in ethanol before staining for markers of inflammation including macrophages (F4/80, AbD Serotec, Oxford, UK). Sections were treated with an antigen-unmasking solution consisting of 10 mM sodium citrate, pH 6.0 and then washed with phosphate-buffered saline (PBS). Sections were incubated with 3% H~2~O~2~ in methanol to block endogenous peroxidase activity. Nonspecific binding was blocked with 10% normal horse serum. After incubating with primary antibody (F4/80 1 : 50) at 4°C overnight, antibodies were visualized with a peroxidase-conjugated secondary antibody using the Vector Impress kit (Vector Laboratories, Burlingame, CA). Sections were then dehydrated in ethanol, cleared in xylene and mounted without counterstaining. All sections were assessed using a color-image analyzer (TDI Scope Eye, Version 3.5 for Windows, Olympus).

2.5. TUNEL Assay {#sec2.5}
----------------

Apoptosis was quantified using an *in situ* detection TUNEL assay kit (Chemicon International, Temecula, CA). The number of TUNEL-positive cells in the kidney was determined using 1,000× magnification.

2.6. Western Blot Analysis {#sec2.6}
--------------------------

Total protein was extracted from the renal cortical tissues with a Pro-Prep Protein Extraction Solution (Intron Biotechnology, Gyeonggi-Do, Republic of Korea) according to the manufacturer\'s instructions. Western blot analysis was performed using the following antibodies: SIRT 1 (1 : 2000, LifeSpan BioSciences, Seattle, WA), Klotho (1 : 5000, Kyowa Hakko Kogyo Co. Ltd, Shizuoka, Japan), PPAR*α* (1 : 1000, Abcam, Cambridge, MA), PGC-1*α* (1 : 2000, Novus Biologicals, Littleton, CO), estrogen-related receptor-1*α* (ERR-1*α*) (1 : 2000, Millipore, Billerica, MA), superoxide dismutase 1 (SOD1) (1 : 5000, Assay Designs, Rochester, NY) and superoxide dismutase 2 (SOD2) (1 : 10000, Abcam), and *β*-actin (1 : 10000, Sigma, St Louis, MO).

2.7. Assessment of Renal Oxidative Stress {#sec2.7}
-----------------------------------------

To evaluate oxidative stress we measured the 24-h urinary 8-epi-prostaglandin F2*α* (isoprostane) (OXIS Health Products Inc., Foster City, CA) concentration.

2.8. Statistical Analysis {#sec2.8}
-------------------------

Data are expressed as means ± standard error (SE). Differences between the groups were examined for statistical significance using ANOVA with Bonferroni correction (SPSS v. 11.5, IBM, Armonk, NY). A *P* value of less than 0.05 was considered significant.

3. Results {#sec3}
==========

3.1. Albuminuria, Serum Creatinine, and Creatinine Clearance {#sec3.1}
------------------------------------------------------------

The 24 M group displayed higher 24 hour albuminuria than the 2 M group (*P* \< 0.05) ([Figure 1(a)](#fig1){ref-type="fig"}). Although the difference was not significant, serum creatinine was increased in the 24 M group compared with the other groups ([Figure 1(b)](#fig1){ref-type="fig"}) and creatinine clearance was also decreased in the 24 M group compared with the 12 M group ([Figure 1(c)](#fig1){ref-type="fig"}). Thus, these results demonstrated that aging is associated with deterioration of renal function.

3.2. Histologic Examination {#sec3.2}
---------------------------

Histological examination revealed that the mesangial area was expanded in the 24 M group by 3.5 and 2.1 times, compared with the 2 M group and 12 M group, respectively (*P* \< 0.01 versus 2 M) (Figures [2(a)](#fig2){ref-type="fig"}, and [2(c)](#fig2){ref-type="fig"}). There was also significantly increased tubulointerstitial fibrosis in the 24 M group, 19 and 18.2 times higher than in the 2 M group and 12 M group, respectively (*P* \< 0.01 versus 2 M) (Figures [2(b)](#fig2){ref-type="fig"}, and [2(d)](#fig2){ref-type="fig"}).

3.3. Immunochemistry for F4/80 and TUNEL Assay {#sec3.3}
----------------------------------------------

Inflammatory cell infiltration, indicated by the presence of positive F4/80 cells, was markedly increased in the 24 M group compared with the 2 M group and 12 M group (*P* \< 0.01 versus 2 M) ([Figure 3](#fig3){ref-type="fig"}). We also investigated TUNEL-positive cells in the kidneys from the three experimental groups. Compared with the 2 M group, the 24 M group had a significantly greater number of TUNEL-positive cells in the glomerulus (*P* \< 0.01 versus 2 M) (Figures [4(a)](#fig4){ref-type="fig"}, and [4(b)](#fig4){ref-type="fig"}) and cortical tubular areas (*P* \< 0.01 versus 2 M) (Figures [4(a)](#fig4){ref-type="fig"}, and [4(c)](#fig4){ref-type="fig"}). These results demonstrate that aging is associated with increased mesangial expansion and tubulointerstitial fibrosis, which could be related to inflammation and apoptosis.

3.4. 24-h Urinary Levels of 8-epi-PGF2*α* {#sec3.4}
-----------------------------------------

Isoprostane concentrations were increased in the 12 M group and 24 M group than in the 2 M group (*P* \< 0.05 and *P* \< 0.01, respectively, versus 2 M) ([Figure 5](#fig5){ref-type="fig"}). These findings indicate that oxidative damage was increased in renal cells from aged mice.

3.5. Expression of SOD1 and SOD2 {#sec3.5}
--------------------------------

By Western blot analysis, we examined the changes in the antioxidant proteins SOD1 and SOD2. The expression of SOD1 and SOD2 were decreased in the 24 M group compared with 2 M group and lower than 12 M group. (*P* \< 0.05 and *P* \< 0.01, resp., versus 2 M) ([Figure 6](#fig6){ref-type="fig"}).

3.6. Expression of SIRT1 {#sec3.6}
------------------------

SIRT1 activation can be influenced by several cellular conditions, such as oxidative stress. The relative content of *SIRT1* protein was measured by Western blot analysis, which showed that the SIRT1 protein levels were markedly decreased in the 24 M group compared with the 2 M group and 12 M group (*P* \< 0.01 versus 2 M) (Figures [7(a)](#fig7){ref-type="fig"}, and [7(b)](#fig7){ref-type="fig"}).

3.7. Expression of PGC-1*α* and ERR-1*α* {#sec3.7}
----------------------------------------

PGC-1*α* exerts a wide array of effects and directly coactivates multiple transcription factors, including nuclear receptors such as the PPARs and ERRs. In the aging kidney, decreased SIRT1 may regulate PGC-1*α*. Western blot analysis showed that PGC-1*α* was decreased in the 24 M group compared with the 2 M group and 12 M group (*P* \< 0.05 versus 2 M) (Figures [7(a)](#fig7){ref-type="fig"}, and [7(c)](#fig7){ref-type="fig"}). There was a gradual decrease in ERR-1*α* expression in the 12 M group and 24 M group compared with the 2 M group (*P* \< 0.01 versus 2 M) (Figures [7(a)](#fig7){ref-type="fig"}, and [7(d)](#fig7){ref-type="fig"}).

3.8. Expression of PPAR*α* {#sec3.8}
--------------------------

PPARs play essential roles in the regulation of cellular differentiation, development, and metabolism and tumorigenesis in higher organisms. PPAR*α* expression in the kidney was lower in the 24 M group compared with that in the 2 M group and 12 M group, as assessed by Western blot analysis (*P* \< 0.01 versus 2 M) ([Figure 8(a)](#fig8){ref-type="fig"}).

3.9. Expression of Klotho {#sec3.9}
-------------------------

Klotho is a transmembrane protein that, in addition to other effects, provides some control over the sensitivity of the organism to insulin and appears to be involved in aging. In the kidney, Klotho is reduced in aging. Our results showed decreased Klotho levels in the 24 M group compared with the 2 M group and the 12 M group (*P* \< 0.01 versus 2 M) ([Figure 8(b)](#fig8){ref-type="fig"}).

4. Discussion {#sec4}
=============

Aging is a multifactorial process characterized by a progressive decline in physiological function. In this study, we investigated the physiologic and pathologic changes related to aging in the kidney. Creatinine clearance decreased and albuminuria increased with aging. There were also increases in mesangial volume, tubulointerstitial fibrosis, inflammation (F4/80 positive cells) and apoptosis. The rate of pathologic change in aging may vary depending on the levels of angiotensin II, nitric oxide (NO), transforming growth factor *β*, advanced glycosylation end product (AGE), oxidative stress and lipid \[[@B12]\]. Our study showed that tissue injury in aging can occur from oxidative stress \[[@B13], [@B14]\] mediated by SIRT1, PGC-1*α*, PPAR*α*, and Klotho \[[@B15]\].

Tissue injury in aging can occur from free radical production and/or antioxidant enzyme deficiency with subsequent lipid peroxidation and oxidative stress \[[@B13], [@B14]\]. Aged kidneys show increased levels of reactive oxygen species and thiobarbiturate acid-reactive substances, which are associated with lipid oxidative damage \[[@B16]\]. In addition, other markers of oxidative stress and lipid peroxidation, such as isoprostanes, AGE, and increased heme oxygenase, are also noted in aged rats \[[@B17]\]. The urine isoprostane excretion increased with age in this study and expression of SOD1 and SOD2 also decreased in 24-month-old mice. Many studies have been performed to assess methods of preventing the aging process with diets enriched in antioxidants such as vitamin E \[[@B17]\] or with angiotensin-converting enzyme inhibitor \[[@B18]\] or angiotensin-receptor blockers. The hemodynamic effect of angiotensin II enhances the aging process in kidney by inducing intraglomerular hypertension and subsequent glomerular damage. It also affects NO synthesis, oxidative stress, immunomodulation, growth factor induction, inflammation, cell migration and apoptosis \[[@B12], [@B19]\]. These finding suggest that renin-angiotensin-aldosterone blockade may be a potential therapeutic treatment to prevent the aging process.

In this study, we showed that SIRT1 expression was decreased in 24-month-old mice. SIRT1 is expressed throughout the body, has broad biological effects, and can significantly affect both cellular survival and longevity during acute and long-term injuries by mechanisms that involve both oxidative stress and cell metabolism \[[@B20]\]. In the cell, SIRT1 uses NAD+ as a substrate, but the level of NAD+ can also control the deacetylating activity of SIRT1. SIRT1 activation can be influenced by several cellular conditions, such as calorie restriction, exercise, and oxidative stress \[[@B21]\]. The hypothetical Sirt1 and AMP-activated protein kinase (AMPK) cycles regulate each other and share many common target molecules, such as PGC-1*α*, PPARs, Forkhead box (FoxO), and NF-*κ*B \[[@B22]\]. It has been suggested that the activation of AMPK and SIRT1 allows for the concurrent deacetylation and phosphorylation of their target molecules and decreases the susceptibility to aging. In the aging kidney, decreased SIRT1 may regulate PGC-1*α*. We suggest that aging-induced suppression of SIRT1/PGC-1*α* signaling may increase oxidative stress in cooperation with AMPK. This signaling may also affect catabolism, mitochondrial function, angiogenesis, inflammation, and insulin resistance \[[@B22]\].

PGC-1*α* exerts a wide array of effects and directly coactivates multiple transcription factors, including nuclear receptors such as the PPARs \[[@B23], [@B24]\] or glucocorticoid receptors \[[@B25]\], estrogen receptors and ERRs \[[@B20], [@B26]\] and nonnuclear receptor transcription factors including myocyte enhancer factor-2 \[[@B27]\] and the FoxO family of transcription factors \[[@B28]\]. By simultaneously coactivating these transcription factors, PGC-1*α* can quickly and coordinately modulate a transcriptional program that governs energy metabolism. Although PGC-1*α* coactivation can change in response to different stimuli or in a tissue-specific manner, in the aging kidney PGC-1*α* exerts effects by enhancing the expression of PPAR*α* and its target molecule ERR-1*α*. ERR-1*α* activation by PGC-1*α* and PPAR*α* induces genes with roles in lipid transport \[[@B29]\], oxidative phosphorylation \[[@B30], [@B31]\], fatty acid oxidation \[[@B32], [@B33]\], the tricarboxylic acid cycle \[[@B23], [@B34], [@B35]\], mitochondrial biogenesis \[[@B30], [@B33]\], and oxidative stress defense \[[@B36]\]. In our study, expression of PGC-1*α*/ERR-1*α* also decreased with aging, which may induce oxidative stress.

PPARs play a critical physiological role in energy homeostasis and inflammation. PPAR*α* stimulation has been shown to increase the NO system in cultured endothelial cells \[[@B37]\] and to induce overexpression both at protein and RNA level of enzymes such as SOD1 in cultured human umbilical vein endothelial cells \[[@B38]\]. PPAR*α* suppression with aging could induce oxidative stress, leading to mesangial expansion and tubulointerstitial fibrosis. PPAR*α* activation may improve renal function during the aging process \[[@B39]\].

The Klotho gene was originally identified as a putative age-suppressing gene in mice that extends lifespan when overexpressed \[[@B35]\]. There are two type of Klotho protein. Membrane Klotho functions as a receptor for a hormone that regulates excretion of phosphate and synthesis of active vitamin D in the kidney. Secreted Klotho functions as a humoral factor with pleiotropic activities, including suppression of growth factor signaling, suppression of oxidative stress, and regulation of ion channels and transporters \[[@B35]\]. Klotho is predominantly expressed in the renal distal tubular cells. Animal studies have showed that the nephroprotective effects of this protein are mostly attributable to the antioxidant properties of its soluble form \[[@B36]\]. Diabetes mellitus, hypertension, kidney diseases, and aging decrease expression of Klotho protein, which then increases sodium/phosphate cotransporter activity and oxidative stress, which in turn induces vascular calcification and endothelial dysfunction. There is emerging data from human studies that suggest that Klotho may be a modifiable factor involved in the pathogenesis of cardiovascular and renal disease in at-risk populations. Further data is required to confirm whether this novel protein has potential as a therapeutic tool that could be used to prevent or slow the progression of cardiorenal disease \[[@B36]\].

5. Conclusions {#sec5}
==============

In conclusion, our results demonstrate that the aging process is associated with deterioration of renal function and increased mesangial expansion and tubulointerstitial fibrosis, which could be accompanied by inflammation, apoptosis and oxidative stress. SIRT1 expression is decreased with aging and may relate to change targets such as PGC-1*α*/ERR-1*α* signaling and PPAR*α*. Reduction in Klotho can also induce oxidative stress. Pharmacologically targeting these signaling molecules may reduce the pathologic changes of aging in the kidney.
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![Increased renal damage in aged mice. The 24 M group displayed higher 24 h albuminuria than other groups ((a) 16.5 ± 1.1 versus 41.5 ± 8.4, 65.5 ± 10.4; \**P* \< 0.05 versus 2 M). Serum creatinine was increased in the 24 M group compared with the other groups ((b) 0.21 ± 0.008 versus 0.12 ± 0.009, 0.68 ± 0.15). Creatinine clearance was decreased in the 24 M group compared with the 12 M group ((c) 0.13 ± 0.004 versus 0.39 ± 0.04, 0.21 ± 0.05; \**P* \< 0.05 versus 2 M). Values are shown as mean ± SE.](OXIMED2012-171383.001){#fig1}

![Renal histopathology of the glomerulus and tubulointerstitial areas. Representative images of PAS ((a) original magnification 400×) and Trichrome stain ((b) original magnification 200×) from renal tissue as indicated. Quantitative assessment of the areas of extracellular matrix in the glomerulus (c) and the tubulointerstitial fibrosis (d) from indicated groups. There was increased mesangial area expansion in the 24 M group compared with other groups (10.1 ± 1.19% versus 17.2 ± 2%, 36.3 ± 3.58%; \*\**P* \< 0.01 versus 2 M), and significantly increased tubulointerstitial fibrosis in the 24 M group compared with other groups. (0.83 ± 0.11% versus 0.87 ± 0.07%, 15.9 ± 1.99%; \*\**P* \< 0.01 versus 2 M). Values are shown as mean ± SE.](OXIMED2012-171383.002){#fig2}

![Immunohistochemistry for F4/80. Result of staining for F4/80-positive cells and quantitative analyses in the 2 M, 12 M, and 24 M groups ((a), original magnification 400×). There was a marked increase in the 24 M group compared with other groups (0.11 ± 0.06% versus 0.4 ± 0.11%, 2.5 ± 0.52%; \*\**P* \< 0.01 versus 2 M). Values are shown as mean ± SE.](OXIMED2012-171383.003){#fig3}

![Increase in apoptotic cells in the glomerulus and tubules of the kidneys from the 24 M group. Representative pictures of TUNEL-positive mesangial cells ((a) original magnification 400×) in the glomerulus and cortical tubular areas for all the study groups. Quantitative analyses of the results are shown ((b) 0.27 ± 0.09% versus 0.53 ± 0.12%, 2.6 ± 0.63%; (c) 0.27 ± 0.09% versus 0.53 ± 0.12%, 2.8 ± 0.67%; \*\**P* \< 0.01 versus 2 M). Values are shown as mean ± SE.](OXIMED2012-171383.004){#fig4}

![Intrarenal 24-h urinary 8-epi-prostaglandin F2*α* (isoprostane) concentrations in all the study groups. Quantitative analyses of the results are shown (7.4 ± 0.3% versus 19.4 ± 0.78%, 21.9 ± 1.9%; \**P* \< 0.05 versus 2 M, \*\**P* \< 0.01 versus 2 M). Values are shown as mean ± SE.](OXIMED2012-171383.005){#fig5}

![Representative Western blots of SOD1 and SOD2. Representative blots from the kidney are shown (a). The expression of SOD1 and SOD2 were decreased in the 24 M group compared with 2 M group and lower than 12 M group. Quantitative analyses of the results are shown (b, c). \**P* \< 0.05 versus 2 M, \*\**P* \< 0.01 versus 2 M.](OXIMED2012-171383.006){#fig6}

![Representative Western blots of SIRT1, PGC-1*α*, and ERR-1*α*. Representative blots from the kidney are shown. (a) Western blot analysis showed that aging markedly decreased SIRT1, PGC-1*α*, and ERR-1*α* protein levels in the 24 M group compared with other groups. Quantitative analyses of the results are shown (b--d). \**P* \< 0.05 versus 2 M, \*\**P* \< 0.01 versus 2 M.](OXIMED2012-171383.007){#fig7}

![Representative Western blots of PPAR*α* and Klotho. Representative blots from the kidney are shown. (a) Western blot analysis showed that aging decreased PPAR*α* and Klotho expression in the 24 M group compared with other groups. Quantitative analyses of the results are shown (b, c). \*\**P* \< 0.01 versus 2 M.](OXIMED2012-171383.008){#fig8}
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